Santen offers grants to clinicians, scientists, and academic institutions (i.e., sponsor investigators) who are pursuing medically and scientifically sound research on our company’s compounds, products of interest, or focus areas within eye health.
We generally support research in the following therapeutic areas:
・Retinal diseases and other posterior segment conditions
・Glaucoma
・Dry eye, corneal disorders, and other anterior segment conditions
Investigators outside the United States, please click here
EVALUATION PROCESS
・To be considered for an IST grant, all applicants must provide comprehensive study details, such as scientific rationale, primary/secondary objectives, study endpoints, projected study design, and fair market study budget.
・Study proposals will be reviewed for scientific merit, validity, and alignment with Santen’s scientific research and business strategies.
・Qualified applicants will be notified of decisions and given feedback as appropriate.
・Accepted and approved proposals will begin the IST clinical research process in adherence with industry and local guidelines and regulations.
Thank you for your interest in Santen’s North America IST program. The application portal is temporarily closed to new applications, as we are restructuring the review process and evaluation criteria. Please check back later for updates. Thank you!
Santen encourages and supports research designed to enhance the understanding of eye diseases and the development of innovative solutions for unmet needs in vision care.
We invite you to explore our grant program below.
Investigator-Sponsored Trials (ISTs)
